The Way to Closed Loop - Dream and Reality

Deutsche medizinische Wochenschrift
Torben BiesterO Kordonouri

Abstract

An old dream of patients with type 1 diabetes and medical teams alike is a fully automated insulin therapy. Available sensor-augmented insulin-pumps are able to intervene in insulin therapy by reducing the dose. Aim of several studies is to add an algorithm to the interaction of pump and sensor, so that insulin doses can be regulated fully automatically. Totally closed loop systems are currently not yet available for outpatient use. Hybrid closed loop systems have been approved in the US. They can improve the metabolic status of patients with type 1 diabetes. Risks are similar to sensor-augmented insulin-pump therapy. Patients' detailed education will continue to be essential for success.

Citations

Sep 15, 2021·Deutsche medizinische Wochenschrift·Nicolin DatzThomas Danne

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Related Papers

The New England Journal of Medicine
Michaela Diamant
The New England Journal of Medicine
Ian BlumerIrl B Hirsch
The New England Journal of Medicine
John C Pickup
© 2022 Meta ULC. All rights reserved